SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

SMS Pharmaceuticals submits newspaper publication

10 Sep 2019 Evaluate

SMS Pharmaceuticals has informed about submission of the copies of advertisement issued in newspapers on Sunday, 8th September, 2019 in Financial Express in English language and in Nava Telangana in Telugu language for the attention of the shareholders of the Company intimating the date of 31st Annual General Meeting, E-Voting and Book Closure. 

The above information is a part of company’s filings submitted to BSE.

SMS Pharmaceuticals Share Price

414.90 -5.70 (-1.36%)
08-May-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1847.30
Dr. Reddys Lab 1293.25
Cipla 1347.70
Zydus Lifesciences 938.90
Lupin 2377.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×